News
Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...
Enter Ionna, a newly launched network of EV “rechargeries” designed not just to top up your car – but to rethink the pit stop. Developed with agency VML, Ionna isn’t selling electricity.
But I am pleased to say there is hope, for I have visited an Ionna charger, and it's everything that chargers should have been from the start. Ionna is funded by eight automakers: BMW, General ...
U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral weight-loss drug news and BMO cut its rating for the Danish drug developer ...
In partnership with VML, which won a competitive pitch, the brand launch of Ionna will use nostalgic design elements that were drawn from America’s automotive past and retro service station brands.
The popularity of Novo Nordisk's Ozempic and Wegovy has attracted competitors and created supply constraints. Novo Nordisk's next-generation weight loss drug disappointed investors in Phase III ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)'s share was trading at $64.49 ...
Novo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular weight-loss med at $499 per month. Novo had only launched the cheaper ...
LONDON (Reuters) -Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries intensify that the obesity drug market ...
Ionna – a joint venture between BMW, General Motors, Honda, Hyundai, Mercedes-Benz, Kia, Stellantis and Toyota – will open a charging station at 2727 Brice Road in Reynoldsburg. It will be the ...
In the sleepy suburb of Bagsværd, a 25-minute train ride from Denmark’s capital of Copenhagen, weight-loss drugmaker Novo Nordisk is everywhere. Street after street is filled with the company ...
German software developer SAP SE unseated Danish weight-loss drug maker Novo Nordisk A/S as Europe’s most-valuable public company. Shares of SAP, which have surged as the Walldorf, Germany-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results